PTC Therapeutics, Inc. v. AcureX Biosciences Corporation, et al.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 PTC THERAPEUTICS, INC., Case No. 25-cv-04594-AMO
Plaintiff,
ORDER RE PLAINTIFF’S MOTION
v. TO DISQUALIFY
ACUREX BIOSCIENCES Re: Dkt. No. 45 CORPORATION, et al., 11 Defendants.
12 Plaintiff PTC Therapeutics, Inc. (“PTC”) asserts Defendants AcureX Biosciences Corporation (“AcureX”), Dr. William Shrader, and Dr. Sean Pintchovski misappropriated trade secrets regarding treatment of neurodegenerative diseases. On August 5, 2025, Defendants moved to unseal the Complaint. (Dkt. No. 33.1) In support of their motion, Defendants submitted the affidavit of Dr. Gladys Monroy, whom PTC contends had a prior attorney-client relationship with BioElectron Technology Corporation (“BioElectron”), PTC’s predecessor-in-interest. (Dkt. No. 34-1.) PTC moves to strike the Monroy Affidavit, as well as disqualify both Dr. Monroy and Cotchett, Pitre & McCarthy, LLP (“CPM”), counsel for Defendants. (Dkt. No. 45.) Defendants oppose the motion. (Dkt.…